I have been sitting on the sidelines for a while, but
I have been sitting on the sidelines for a while, but paying attention to the board here and there. Figure that today's news is a worthwhile time to ponder out load and post some brain droppings:
Last year IPIX first indicated that they were in talks with parties interested in B-OM. Then it evolved into the August non-binding term sheet for B-OM AND IBD indications. Given that IBD indications is a broad spectrum which includes UP/UC, I cant help but think that the new term sheet, now specifically for UP/UC, indicates that the potential partner is a different company. Because I just cant see why the first potential partner would drop B-OM and IBD indications and re-sign a new sheet just for UP/UC with later options of the irst right of refusal for the other IBD indications. Plus I dont recall the August announcements indicating a Global pharma company as the group for the first term sheet. (I think I may just be recalling that incorrectly, so if someone can confirm or deny that I'd appreciate it. I dont have the time to go do the research just for the sake of this post. I have a day job that doesn't include being paid to troll SMBs.)
Regardless, it seems logical to me that this new sheet is with a new partner and poses a few scenarios:
1) The offer with this new partner is better than the first term sheet for B-OM with the IBD indications as an adder. So IPIX is going after a more lucrative deal.
2) This negates the B-OM term sheet since IBD is now off the table. Which either allows IPIX to have more leverage with potential B-OM partner for a better deal. Leaves IPIX to negotiate B-OM on its own with other suitors. Or the expected upfront money will allow IPIX to keep going it alone with B-OM to progress the trails and make the asset even more valuable.
3) IPIX has two term sheets and two potential partners for the specified indications.
I am sure that reality is likely way different then my musings, but at least we know that another significant concrete step has been made by IPIX on the road to success.
I cant wait for more news to develop!!!!!! Still holding long and strong on this one!!!! (oh and I convinced my brother in-law to by some thousands of shares down in the .10's. So he's stoked about the news too.)
2
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Pushing AI Regulations into High Gear I'll tell you what—it's about time somebody shook things up in the AI world with more than empty promises. Governor Newsom's executive order is doing just that, fast-tracking the timeline for implementing California's SB 813. This move is like giving speed boots to the legislative process, revving up the rules to ensure AI doesn't...
Continue Reading
Unlikely Spotlight on Menopause at Capitol Hill If you told me a couple of years back that menopause would become a front-page political issue, I would've laughed. Yet, here we are, with over 125 advocates from 29 states converging on Washington, D.C., demanding legislative action on menopause. Why Menopause Matters in Policy The fact that more than half the population is...
Continue Reading
AI's Increasing Role: A Double-Edged Sword for Leaders Hey, the tech overlords remind us once again—the future doesn't wait for anyone to catch up before it bulldozes forward. Info-Tech Research Group has sounded the alarm on AI agents muscling their way into product decisions without any clear nod from the human corner office. Blurring Lines of Accountability The...
Continue Reading
A Month to Celebrate Unseen Heroes Take a pause. We're talking about National Service Dog Month. What in the world could be more endearing than a pack of puppies, those hopeful bundles of joy, destined to grow up and play pivotal roles in people's lives? Canine Companions is rolling out the red carpet for these future heroes, with a nine-day Puppy Cam event from September...
Continue Reading
The Sky's Not the Limit—It's Just the Beginning Step aside, conventional paths. There's a flight school owner in Sedona, Arizona, making waves by encouraging girls to swap their land-bound dreams for sky-high aspirations. This International Girls in Aviation Day, Michelle Smith wants young dreamers to know their possibilities span as wide as the open sky. Defying...
Continue Reading
End of an Era: Warren Buffett's Retirement Warren Buffett—there's a name that's echoed through the halls of investment for decades. Today, he's pulling down the curtain as Chairman of Berkshire Hathaway (NYSE: BRK). No fanfare, just a nod to the inevitable with his classic, humor-tinged confession: 'Father Time always wins.' Can’t argue with the man who’s seen the...
Continue Reading
Paving Pathways in the Chemical Industry There's something brewing that's got me eyeing the future with cautious optimism, and it doesn't involve hedge funds or earnings reports. It's the Future of STEM Scholars Initiative (FOSSI) playing its cards just right, planting seeds for tomorrow's innovators. This puppy opened the gates for 2027 applications, and for young brains...
Continue Reading
Navigating the AI Terrain in Arbitration It's 2026 and artificial intelligence isn't just a buzzword anymore; it's reshaping every corner of how disputes get resolved. The American Arbitration Association (AAA) has jumped into the mix, launching an AI Ambassador program to tackle a wave of AI-induced challenges. These aren't just academic exercises—this is a hard-nosed...
Continue Reading
New Kid on the Block: Cheez Nugs Buckle up folks, Crimson Coward is at it again. They're rolling out something they claim will blow your taste buds straight out of the water: Cheez Nugs. Dropping nationwide on September 18, 2026, these aren't your run-of-the-mill cheese bites. We're talking 100% whole-milk mozzarella, a golden herb-seasoned crust, and a mouthful of creamy...
Continue Reading
A Decade of Dedication Some stories out there bring a much-needed shine to the otherwise relentless grind, and this is one of those rare gems. No Dogs Left Behind (NDLB) is celebrating a monumental milestone: ten years into their mission, they've crossed the incredible threshold of saving over 10,000 dogs from the clutches of slaughterhouses in East Asia. The nonprofit...
Continue Reading
Top 5 Most Recently Viewed Articles
Experience a Heartfelt Gathering at Festival Beach Storytelling and celebration come alive at the Festival Beach Food Forest, inviting everyone to join in on a special Summer Solstice gathering. This event, sponsored by Tractor Beverage Company’s Mad Farmer Tour, promises a unique experience centered around food, community, and sustainability. Celebrating Nature and...
Continue Reading
Legal Challenges for UnitedHealth Group, Inc. UnitedHealth Group, Inc. (NYSE: UNH) is currently facing significant legal scrutiny as a result of new shareholder lawsuits. These actions come in the wake of a concerning federal investigation into the company's Medicare billing procedures, which has been highlighted in recent media pieces. Overview of the Latest Legal Action...
Continue Reading
Stoneridge Completes Strategic Sale of Control Devices Segment Stoneridge, Inc. (NYSE: SRI) has reached a significant milestone by successfully completing the sale of its Control Devices segment. This transaction marks a pivotal move in the company’s long-term strategy aimed at enhancing its core operations. Details of the Sale The sale was finalized with a base...
Continue Reading
Services PMI Shows Positive Growth in September 2024 The Services PMI registered an impressive reading of 54.9 percent in September 2024, marking a significant increase and indicating expansion within the service sector. This marks the highest level seen since earlier this year and reflects a continued trend of growth within the industry. Key Metrics and Indices Key...
Continue Reading
Juan Bianchi’s Recent Stock Sale: What It Could Mean for You Juan Bianchi, the CEO of Euronet Worldwide, recently reported a sizable insider sale. According to a Form 4 filed with the SEC, he sold 16,440 shares for a total of $1,662,903. Insider moves like this tend to catch investors’ eyes, and for good reason: they can hint at an executive’s personal view of risk,...
Continue Reading